Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2009

01.09.2009 | Original Article

Helicobacter pylori Infection as a Risk Factor for Insulin Resistance

verfasst von: Ahad Eshraghian, Seyed Ali Hashemi, Alireza Hamidian Jahromi, Hamed Eshraghian, Seyed Masoum Masoompour, Mohamad Ali Davarpanah, Kavus Eshraghian, Seyed Alireza Taghavi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to determine the relation between Helicobacter pylori infection and insulin resistance in healthy subjects. In a cross-sectional case control study between January and April 2007, a total of 71 healthy subjects without the exclusion criteria completed the study. Forty-three (60.6%) patients were H. pylori positive and 28 (39.4%) patients were H. pylori negative. Age and body mass index of the patients were not significantly different between the two groups (32.2 ± 14.2 vs. 33 ± 8.05 years and 23.15 ± 4.5 vs. 24.04 ± 3.2 kg/m2, respectively). H-pylori-positive patients had significantly higher HOMA-IR level compared to H-pylori-negative patients (3.54 ± 2.2 vs. 2.46 ± 1.9, respectively) (< 0.05). Fasting serum insulin level was significantly higher in the H-pylori-positive group compared with the H-pylori-negative group (19.41 ± 3.08 vs. 16.57 ± 2.02 μU/ml, respectively) (< 0.05). Our findings suggest recognition of H. pylori infection as a risk factor for insulin resistance.
Literatur
4.
Zurück zum Zitat Misiewicz JJ. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995;7:701–703.PubMed Misiewicz JJ. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995;7:701–703.PubMed
5.
Zurück zum Zitat Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol. 2003;29:351–359.PubMed Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol. 2003;29:351–359.PubMed
7.
Zurück zum Zitat Moller DE, Flier J. Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325:938–948.PubMed Moller DE, Flier J. Insulin resistance mechanisms, syndromes and implications. N Engl J Med. 1991;325:938–948.PubMed
10.
Zurück zum Zitat Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996–1001.PubMed Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996–1001.PubMed
15.
Zurück zum Zitat Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. doi:10.2337/diacare.23.1.57.PubMedCrossRef Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63. doi:10.​2337/​diacare.​23.​1.​57.PubMedCrossRef
22.
23.
Zurück zum Zitat Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29:1058–1064. doi:10.2337/dc05-2068.PubMedCrossRef Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care. 2006;29:1058–1064. doi:10.​2337/​dc05-2068.PubMedCrossRef
26.
Zurück zum Zitat Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest. 1984;74:417–423. doi:10.1172/JCI111437.PubMedCrossRef Colturi TJ, Unger RH, Feldman M. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest. 1984;74:417–423. doi:10.​1172/​JCI111437.PubMedCrossRef
27.
31.
Zurück zum Zitat Salles N, Ménard A, Georges A, et al. Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. J Gerontol A Biol Sci Med Sci. 2006;61:1144–1150.PubMed Salles N, Ménard A, Georges A, et al. Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. J Gerontol A Biol Sci Med Sci. 2006;61:1144–1150.PubMed
33.
Zurück zum Zitat Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol. 2005;7:695–699. Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol. 2005;7:695–699.
34.
Zurück zum Zitat Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMed Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470–1476.PubMed
35.
Zurück zum Zitat Park SH, Jeon WK, Kim SH, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97:508–513.PubMed Park SH, Jeon WK, Kim SH, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97:508–513.PubMed
36.
Zurück zum Zitat Ozdem S, Akcam M, Yilmaz A, Artan R. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest. 2007;30:36–40. Ozdem S, Akcam M, Yilmaz A, Artan R. Insulin resistance in children with Helicobacter pylori infection. J Endocrinol Invest. 2007;30:36–40.
37.
Zurück zum Zitat Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229–238. doi:10.1016/j.ijcard.2006.12.003.PubMedCrossRef Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229–238. doi:10.​1016/​j.​ijcard.​2006.​12.​003.PubMedCrossRef
Metadaten
Titel
Helicobacter pylori Infection as a Risk Factor for Insulin Resistance
verfasst von
Ahad Eshraghian
Seyed Ali Hashemi
Alireza Hamidian Jahromi
Hamed Eshraghian
Seyed Masoum Masoompour
Mohamad Ali Davarpanah
Kavus Eshraghian
Seyed Alireza Taghavi
Publikationsdatum
01.09.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0557-7

Weitere Artikel der Ausgabe 9/2009

Digestive Diseases and Sciences 9/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.